New Therapies for Treating Hepatitis C Virus: Impact on Laboratory Testing Recommendations and Clinical Management.

Saved in:
Bibliographic Details
Title: New Therapies for Treating Hepatitis C Virus: Impact on Laboratory Testing Recommendations and Clinical Management.
Authors: Tolan NV; Department of Laboratory Medicine and Pathology, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA; nicole.tolan@sciex.com., Horowitz GL; Department of Pathology and Laboratory Medicine, Tufts Medical Center and Tufts University School of Medicine, Boston, MA., Graham CS; Assistant Professor of Medicine, Harvard Medical School and Beth Israel Deaconess Medical Center, Boston, MA., Hillyard D; Professor of Pathology, University of Utah; Medical Director of the Molecular Hepatitis and Retrovirus and Molecular Infectious Diseases laboratories and the Molecular Infectious Diseases and Molecular Hepatitis/Retrovirus sections, ARUP, Salt Lake City, UT., Osburn W; Assistant Professor of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD., Ray S; Professor of Medicine and Vice-Chair of Medicine for Data Integrity and Analytics, Johns Hopkins University School of Medicine, Baltimore, MD.
Source: Clinical chemistry [Clin Chem] 2017 Dec; Vol. 63 (12), pp. 1799-1805. Date of Electronic Publication: 2017 Oct 10.
Publication Type: Interview
Journal Info: Publisher: Oxford University Press Country of Publication: England NLM ID: 9421549 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1530-8561 (Electronic) Linking ISSN: 00099147 NLM ISO Abbreviation: Clin Chem Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1530-8561
DOI:10.1373/clinchem.2016.266569